DNAY Stock Performance, Insider Transaction and News

DNAY - Codex DNA, Inc.

Market Cap	38.38M	P/E	-	EPS this Y	14.50%	Ern Qtrly Grth	-
Income	-52.83M	Forward P/E	-0.85	EPS next Y	16.40%	50D Avg Chg	-7.00%
Sales	21.04M	PEG	-	EPS past 5Y	-	200D Avg Chg	-45.00%
Dividend	N/A	Price/Book	0.72	EPS next 5Y	-	52W High Chg	-88.00%
Recommedations	1.70	Quick Ratio	4.33	Shares Outstanding	29.52M	52W Low Chg	20.00%
Insider Own	37.14%	ROA	-29.63%	Shares Float	7.53M	Beta	-
Inst Own	43.64%	ROE	-67.70%	Shares Shorted/Prior	133.25K/325.67K	Price	1.30
Gross Margin	47.67%	Profit Margin	-251.05%	Avg. Volume	79,397	Target Price	6.50
Oper. Margin	-239.49%	Earnings Date	Nov 8	Volume	19,945	Change	8.33%

Healthcare | Medical Devices | United States

About Codex DNA, Inc.

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

DNAY Chatroom

JOEYBUYDEN Posted - 2 months ago

$PFE would have already purchased $TBIO formerly $DNAY if they thought their bench top technology was worth it. They did NOT. ✔️ Instead they quit investing. This company is dead, bury it!! 🪦🪦🪦

JOEYBUYDEN Posted - 2 months ago

@Traderoca did I tell you I already lost $10,000 on this stock and sold it off to mitigate Disney gains. Yes I understand- but I highly doubt this POS company ever makes a comeback so you can sit around and wait 5-10 years for that if ever. I have been following their news and financials long enough to realize it’s not going anywhere. I was here when it was $DNAY but you probably don’t know nothing about that…

NVDAMillionaire Posted - 3 months ago

$DNAY Telesis Bio Inc. (NASDAQ:DNAY): Navigating the Synthetic Biology Landscape with Innovative Solutions http://beyondspx.com/2024/08/05/telesis-bio-inc-nasdaqdnay-navigating-the-synthetic-biology-landscape-with-innovative-solutions/

Alex_Hudson Posted - 3 months ago

$DNAY MACD Cross Above Signal Line.

PeteFromPhilly Posted - 5 months ago

$AMC $DNAY Hey @papertrader_US I think @CallMeMyB new nickname is 400 Percent 😂😂

VertanosTrading Posted - 8 months ago

$DNAY why is this 130% up? 😂

VertanosTrading Posted - 8 months ago

$DNAY why is this up 30%?

cctranscripts Posted - 11 months ago

Codex DNA, Inc.'s Chief Financial Officer was just granted 300,000 options https://www.conferencecalltranscripts.org/summary/?id=12766670 $DNAY

cctranscripts Posted - 11 months ago

Codex DNA, Inc.'s Chief Financial Officer just declared ownership of no shares of Codex DNA, In https://www.conferencecalltranscripts.org/summary/?id=12766641 $DNAY

cctranscripts Posted - 11/30/23

Entry into a Material Definitive https://www.conferencecalltranscripts.org/summary/?id=12753933 $DNAY

cctranscripts Posted - 1 year ago

Codex DNA, Inc. Just Filed Its Quarterly Report: 15.NET LOSS PER SHAR... https://www.conferencecalltranscripts.org/summary/?id=12702143 $DNAY

cctranscripts Posted - 1 year ago

Codex DNA: Telesis Bio Reports Third Quarter 2023 Financial Results https://www.conferencecalltranscripts.org/summary/?id=12702112 $DNAY

EarningsInsider Posted - 1 year ago

Telesis Bio, Inc. Files SEC Form 10-Q $DNAY https://www.marketbeat.com/stocks/NASDAQ/DNAY/sec-filings/

EarningsInsider Posted - 1 year ago

Telesis Bio, Inc. Files SEC Form 8-K $DNAY https://www.marketbeat.com/stocks/NASDAQ/DNAY/sec-filings/

risenhoover Posted - 1 year ago

$DNAY / Codex DNA files form 10-Q https://fintel.io/doc/sec-telesis-bio-inc-1850079-10q-2023-november-13-19674-594?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

risenhoover Posted - 1 year ago

$DNAY / Codex DNA files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 https://fintel.io/doc/sec-telesis-bio-inc-1850079-8k-2023-november-13-19674-9861?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

cctranscripts Posted - 1 year ago

Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation u https://www.conferencecalltranscripts.org/summary/?id=12694027 $DNAY

EarningsInsider Posted - 1 year ago

Telesis Bio, Inc. Files SEC Form 8-K $DNAY https://www.marketbeat.com/stocks/NASDAQ/DNAY/sec-filings/

cctranscripts Posted - 10/25/23

Codex DNA, Inc. director just declared ownership of no shares of Codex DNA, Inc. https://www.conferencecalltranscripts.org/summary/?id=12639620 $DNAY

cctranscripts Posted - 10/25/23

Codex DNA, Inc. director just picked up 153,191 shares https://www.conferencecalltranscripts.org/summary/?id=12639618 $DNAY

cctranscripts Posted - 10/24/23

Departure of Directors or Certain https://www.conferencecalltranscripts.org/summary/?id=12636695 $DNAY

cctranscripts Posted - 1 year ago

Departure of Directors or Certain https://www.conferencecalltranscripts.org/summary/?id=12561397 $DNAY

Quantisnow Posted - 1 year ago

$DNAY 📜 Codex DNA Inc. filed SEC Form 8-K: Leadership Update https://quantisnow.com/i/4984909?utm_source=stocktwits 45 seconds delayed.

macroaxis Posted - 1 year ago

$DNAY - Symbol renaming can cause some disturbance for Codex DNA https://www.macroaxis.com/predict/DNAY/Codex-DNA #stocks #earnings

cctranscripts Posted - 08/29/23

Codex DNA: Telesis Bio Appoints William J. Kullback Chief Financial Officer https://www.conferencecalltranscripts.org/summary/?id=12496089 $DNAY

macroaxis Posted - 1 year ago

$DNAY - Enters -0.0418 Risk Adjusted Performance. Symbol was renamed to TBIO on 4th of January 2023 https://www.macroaxis.com/invest/technicalIndicator/DNAY/Risk-Adjusted-Performance #stocks #earnings

cctranscripts Posted - 1 year ago

Codex DNA, Inc. Just Filed Its Quarterly Report: 15.NET LOSS PER SHAR... https://www.conferencecalltranscripts.org/summary/?id=12446474 $DNAY

risenhoover Posted - 1 year ago

$DNAY / Codex DNA files form 10-Q https://fintel.io/sf/us/dnay?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Quantisnow Posted - 1 year ago

$DNAY 📜 SEC Form 10-Q filed by Codex DNA Inc. https://quantisnow.com/i/4881354?utm_source=stocktwits 45 seconds delayed.

cctranscripts Posted - 1 year ago

Codex DNA: Telesis Bio Reports Second Quarter 2023 Financial Results https://www.conferencecalltranscripts.org/summary/?id=12443534 $DNAY

Analyst Ratings

Keybanc	Overweight	Nov 9, 22
Keybanc	Overweight	Mar 28, 22
Jefferies	Buy	Jul 13, 21
Cowen & Co.	Outperform	Jul 13, 21
Keybanc	Overweight	Jul 13, 21